Hormone Receptor (HR)-Positive Breast Cancer
2 clinical trials · Condition
◉ Watch Hormone Receptor (HR)-Positive Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Palbociclib With Everolimus + Exemestane In BC (NCT02871791) | Dana-Farber Cancer Institute | 2016-08-24 |
Track Hormone Receptor (HR)-Positive Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.